Provided by Tiger Fintech (Singapore) Pte. Ltd.

GT Biopharma Inc.

2.84
+0.02000.71%
Post-market: 2.78-0.0600-2.11%19:52 EDT
Volume:67.89K
Turnover:195.51K
Market Cap:7.35M
PE:-0.41
High:3.01
Open:2.92
Low:2.75
Close:2.82
Loading ...

BRIEF-GT Biopharma Appoints New Member To Its Board Of Directors

Reuters
·
13 Jun

GT Biopharma Appoints New Member to Its Board of Directors

THOMSON REUTERS
·
13 Jun

GT Biopharma files to sell 120.55M shares of common stock for holders

TIPRANKS
·
12 Jun

GT Biopharma Inc. Appoints David C. Mun-Gavin as New Non-Employee Director and Chair of Compensation Committee Following Andrew Ritter's Departure

Reuters
·
12 Jun

GT Biopharma Inc. Files Initial Statement of Beneficial Ownership for Director Hilary Kramer

Reuters
·
04 Jun

GT Biopharma Inc. Files Initial Statement of Beneficial Ownership for Director Andrew J. Ritter

Reuters
·
30 May

GT Biopharma advances GTB-3650 Phase 1 trial to Cohort 2

TIPRANKS
·
19 May

BRIEF-GT Biopharma Advances GTB-3650 Phase 1 Trial to Cohort 2 Following Successful Initial Human Dosing and Evidence of Early Immune Activation Signals

Reuters
·
19 May

GT Biopharma Inc - Detailed Phase 1 Results Expected Later in 2025

THOMSON REUTERS
·
19 May

GT Biopharma Inc - No Safety Issues in Cohort 1, Cohort 2 Proceeds

THOMSON REUTERS
·
19 May

GT Biopharma Advances Gtb-3650 Phase 1 Trial to Cohort 2 Following Successful Initial Human Dosing and Evidence of Early Immune Activation Signals

THOMSON REUTERS
·
19 May

GT Biopharma Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
17 May

GT Biopharma Q1 EPS $(0.33) Beats $(0.64) Estimate

Benzinga
·
16 May

GT Biopharma Appoints New Member to Its Board of Directors

THOMSON REUTERS
·
15 May

GT Biopharma Inc expected to post a loss of 64 cents a share - Earnings Preview

Reuters
·
15 May

Five Narrow Lane Lp Reports 9.99% Passive Stake in GT Biopharma as of May 13- SEC Filing

THOMSON REUTERS
·
14 May

BRIEF-GT Biopharma Appoints New Member To Its Board Of Directors

Reuters
·
14 May

GT Biopharma Appoints New Member to Its Board of Directors

THOMSON REUTERS
·
14 May

GT Biopharma Inc. Announces Board Restructuring with New Appointments and Resignations

Reuters
·
14 May

GT Biopharma Inc expected to post a loss of 64 cents a share - Earnings Preview

Reuters
·
10 May